Griffiths Chris, Levy Mark L
Blizard Institute, London, UK.
Practitioner. 2014 Sep;258(1774):27-31, 3.
The UK has one of the highest death rates in Europe from asthma, with more than 20 people dying from the disease each week. Across the UK there is a five-fold variation in the number of hospital admissions for asthma almost certainly explained in part by variations in delivery, uptake and organisation of care. Deaths from asthma are frequently avoidable the findings from the National Review of Asthma Deaths have confirmed. A total of 276 cases were considered by the confidential enquiry panels and 195 confirmed as asthma deaths. Major avoidable factors were judged to be present in 60% of cases. Key findings from the report include: Almost half the patients (45%) died without seeking medical help or before help could be provided; 10% died within 28 days of discharge from hospital; 21% had attended A&E with asthma in the previous year; and only 23% had a personal asthma action plan. Over-prescription of short-acting bronchodilators and under-prescription of preventer inhalers was common. Every general practice should have a designated, named clinical lead for asthma services. Patients with asthma should be referred to a specialist asthma service if they have required more than two courses of systemic corticosteroids, oral or injected, in the previous 12 months or management using BTS steps 4 or 5 to achieve control. Any patient admitted to hospital or attending A&E with asthma should be reviewed, and control optimised, within a week of discharge. All asthma patients should have a written personal asthma action plan and should have a structured review by a healthcare professional with training. in asthma at least annually.
英国是欧洲哮喘死亡率最高的国家之一,每周有超过20人死于该疾病。在英国,哮喘住院人数相差五倍,这几乎可以肯定部分是由医疗服务的提供、接受和组织差异所导致的。哮喘死亡往往是可以避免的,哮喘死亡全国审查的结果已经证实了这一点。保密调查小组共审议了276个病例,其中195个被确认为哮喘死亡病例。60%的病例被判定存在主要的可避免因素。该报告的主要发现包括:近一半的患者(45%)在未寻求医疗帮助或在得到帮助之前就死亡了;10%的患者在出院后28天内死亡;21%的患者在前一年曾因哮喘去过急诊室;只有23%的患者有个人哮喘行动计划。短效支气管扩张剂处方过量和预防吸入器处方不足的情况很常见。每个全科诊所都应该有一位指定的、具名的哮喘服务临床负责人。如果哮喘患者在过去12个月内需要超过两个疗程的全身性皮质类固醇(口服或注射),或者使用英国胸科学会第4或5步进行管理以实现控制,就应该转诊至专科哮喘服务机构。任何因哮喘住院或去过急诊室的患者在出院后一周内都应该接受复查,并优化控制措施。所有哮喘患者都应该有一份书面的个人哮喘行动计划,并且应该至少每年由接受过哮喘培训的医疗专业人员进行一次结构化复查。